Preferred Name | pirbuterol | |
Synonyms |
Maxair pyrbuterol CP-24315-1 pirbuterol acetate pirbuterol acetate salt CP 24315-1 pirbuterol dihydrochloride 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-tert-butylamino ethyl)pyridine, dihydrochloride CP-24,314-1 pirbuterol sulfate |
|
ID |
http://purl.bioontology.org/ontology/MESH/C009118 |
|
altLabel |
Maxair pyrbuterol CP-24315-1 pirbuterol acetate pirbuterol acetate salt CP 24315-1 pirbuterol dihydrochloride 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-tert-butylamino ethyl)pyridine, dihydrochloride CP-24,314-1 pirbuterol sulfate |
|
cui |
C0110845 C0721597 C0724666 C0951987 C1130484 C0071129 C0951988 |
|
HM |
D004983 |
|
Inverse of RB |
J6793T658K OG645J8RVW 1EH73XKR9N 66546-54-1 |
|
isa |
http://purl.bioontology.org/ontology/MESH/D058666 |
|
LT |
TRD |
|
Mapped to | ||
MDA |
19750101 |
|
MeSH Frequency |
113 |
|
MMR |
20161223 |
|
notation |
C009118 |
|
PA |
D001993 D058666 D002316 |
|
PI |
BUTYLAMINES (75-78) *PYRIDINES (75-78) PYRIDINES (78-80) ETHANOLAMINES (75-78) |
|
prefLabel |
pirbuterol |
|
RR |
J6793T658K 38029-10-6 (pirbuterol dihydrochloride) 1EH73XKR9N 66546-54-1 38677-81-5 (pirbuterol) |
|
SC |
1 |
|
Scope Statement |
structure |
|
SRC |
Biomed Mass Spectrom 3(5):207;1976 Br J Dis Chest 1080;74(1):70 Br J Clin Pharmacol 4(3):376;1977 J Pharmacol Exp Ther 208(3):371;1979 J Pharmacol Exp Ther 207(2):410;1978 Clin Pharmacol Ther 24(1):84;1978 Curr Ther Res 16(10):1077;1974 Ann Allergy 1979;43(6):348 Eur J Clin Pharmacol 1979;15(6):389 Int J Clin Pharmacol Biopharm 17(1):18;1979 Int J Clin Pharmacol Biopharm 17(6):237;1979 J Pharm Sci 66(6):819;1977 |
|
TERMUI |
T083539 T083540 T083543 T340598 T463294 T340597 T083542 T083541 T083545 T083544 T340596 |
|
TH |
FDA SRS (2013) NLM (1975) NLM (2001) USAN (19XX) INN (19XX) FDA SRS (2015) USAN (1975) |
|
tui |
T109 T121 |